Navigation Links
Nile Therapeutics, Inc. Completes $1.34 Million Registered Direct Offering
Date:4/4/2012

SAN MATEO, Calif., April 4, 2012 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has completed its previously announced sale of an aggregate of 3.35 million shares of its common stock and warrants to purchase an additional 2,512,500 shares of common stock at an initial exercise price of $0.50 per share.  The total gross proceeds from the registered direct offering were $1.34 million, before deducting selling commissions and expenses of approximately $0.2 million.

The company plans to use the net proceeds from the offering for general corporate purposes, including funding its activities related to planning and designing its next Phase 2 clinical trial of cenderitide. 

Roth Capital Partners, LLC acted as sole placement agent in the offering.

The securities were sold pursuant to a shelf registration statement (File No. 333-165167), which was declared effective by the United States Securities and Exchange Commission ("SEC") on March 12, 2010. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A prospectus supplement relating to the offering has been filed with the SEC.  Copies of the prospectus supplement and the accompanying base prospectus may be obtained at the SEC's website at www.sec.gov.

About Post-Acute Heart Failure

Heart failure is the fastest-growing clinical cardiac disease in the U.S. according to the American Heart Association, affecting over 5 million Americans. Over 1 million
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- According to a new market research ... (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement ... Forecast to 2019", published by MarketsandMarkets, the global Body ... and is estimated to grow to $1,425.7 Million by ... to 2019. Browse 41 market data ...
(Date:7/30/2015)... , July 30, 2015  ResMed (NYSE: ... signed a definitive agreement to acquire Curative ... ventilation and sleep-disordered breathing medical devices and ... market reputation in China, combined with ResMed,s global leadership in sleep and ... China suffering from ...
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
(Date:7/31/2015)... ... 31, 2015 , ... Indosoft, Inc., is pleased to announce a major update ... their flagship contact center ACD system for Asterisk-based call centers . The new ... script components to the agent only when wanted, and allows for validation of data ...
(Date:7/31/2015)... Minneapolis, Minn. (PRWEB) , ... July 31, 2015 ... ... software, is selected as a contributor for LeadingAge’s Center for Aging Services Technologies ... studies designed to help long-term and post-acute care providers understand the benefits of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Beaumont Hospital's Karmanos Center for Natural Birth . The Karmanos Center ... a safe natural childbirth experience. With nurses and caregivers that are trained in ...
(Date:7/31/2015)... ... 2015 , ... New Energy Works Timberframers invites the public to join their ... 2015 from 9am – 12pm. Timber frame raisings are special, celebrating both ... as the culmination of months of effort, planning, fundraising, and dreaming takes shape. ...
(Date:7/31/2015)... ... July 31, 2015 , ... An article entitled " Dentists ... a woman’s unfortunate experience having cosmetic skin procedures done by a family doctor ... blistering, swelling, bruising, and pain. This woman’s experience is only one in a ...
Breaking Medicine News(10 mins):Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3
... response has practical application, expert says , SUNDAY, Jan. 17 ... into why we miss things when they,re uncommon. , ... often don,t find it," said Jeremy Wolfe of Harvard Medical ... news release from Cell Press, which published a study on ...
... ... by advocating for physician patient relationships which ensure optimal patient care and well being, ... guidelines such as breast cancer screening that can negatively impact patients. , ... (PRWEB) January 17, 2010 -- ...
... The world-renowned wellness ... balm based on the timeless healing principles of ayurvedic medicine , ... Carlsbad, CA (PRWEB) January 17, 2010 -- Made ... this winter season. Adara Lip Balm heals dry, chapped lips with a signature blend of ...
... , - More relief goods, staff arrive, but challenges ... , - Agency reports "race against clock" to save lives ... , Jan. 16 World Vision relief ... a boost as relief goods began arriving in Haiti,s quake-ravaged capital city ...
... , ... Latin America , WASHINGTON , Jan. 16 ... Haiti relief efforts using a new Portuguese website called ... of American States announced. , AjudaPanamericana.org is the third language option ...
... , WASHINGTON , Jan. ... Development (USAID) Bureau for Global Health is sending additional specialists ... medical needs.  Reports indicate that thousands of individuals in makeshift ... Tuesday,s earthquake. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO ) , Global ...
Cached Medicine News:Health News:Southern Medical Association Takes Position on Breast Cancer Screening 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 3Health News:Southern Medical Association Takes Position on Breast Cancer Screening 4Health News:Pamper and Soothe Your Lips with the Chopra Center's New Adara Certified Organic Lip Balm 2Health News:HAITI QUAKE: World Vision Situation Update 2Health News:HAITI QUAKE: World Vision Situation Update 3Health News:HAITI QUAKE: World Vision Situation Update 4Health News:Haiti Relief Site Now in Portuguese 2Health News:Haiti Relief Site Now in Portuguese 3Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 3
... Further expanding the growing portfolio ... Pulse Oximeter is a compact, affordable ... advanced signal processing technology, it offers ... and is compatible with the complete ...
... of the revolutionary OxiMax® Pulse Oximetry ... combines Nellcor's best-in-class pulse oximetry with ... motion-tolerant OxiMax N-595 Pulse Oximeter is ... processing technology, which enables it to ...
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m...
The Model 340 is intended for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
Medicine Products: